Annovis Bio, Inc. operates as a biotechnology company. The Company develops drugs for alzheimer's and parkinson's disease, including the orphan indication dementia and alzheimer's in down syndrome. Annovis Bio serves customers in the State of Pennsyl... Read more
MarketWatch
MarketWatch
MarketWatch
CNBC
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.